Immatics (IMTX) Other Non-Current Liabilities (2019 - 2025)

Immatics (IMTX) reported Other Non-Current Liabilities of $7.8 million for Q3 2025, down 51.78% on a YoY basis from $16.2 million in Q3 2024, and up 5488.71% sequentially from $139900.6 in Q1 2025.

Immatics (IMTX) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Other Non-Current Liabilities data on file, last reported at $7.8 million in Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities fell 51.78% year-over-year to $7.8 million; the trailing twelve-month figure through Sep 2025 stood at $7.8 million (down 51.78% YoY), and the FY2024 full-year result was $1.9 million, up 43174.82% from the prior year.
  • Other Non-Current Liabilities advanced to $7.8 million in Q3 2025, from $139900.6 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $19.5 million in Q1 2024 to a low of $4303.8 in Q4 2023.
  • A 5-year average of $3.1 million and a median of $77790.0 in 2021 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities jumped 74378.01% in 2024 and sank 99.28% in 2025, its largest moves.
  • Tracing IMTX's Other Non-Current Liabilities over 5 years: stood at $77790.0 in 2021, then tumbled by 44.92% to $42850.4 in 2022, then slumped by 89.96% to $4303.8 in 2023, then surged by 42854.77% to $1.8 million in 2024, then soared by 322.93% to $7.8 million in 2025.
  • Business Quant data shows IMTX's Other Non-Current Liabilities at $7.8 million in Q3 2025, $139900.6 in Q1 2025, and $1.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Immatics 1.11 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 7.82 Mn
Mar 31, 2025 139,900.63
Dec 31, 2024 1.85 Mn
Sep 30, 2024 16.22 Mn
Mar 31, 2024 19.50 Mn
Dec 31, 2023 4,303.76
Sep 30, 2023 21,771.81
Jun 30, 2023 28,312.03
Mar 31, 2023 35,420.28
Dec 31, 2022 42,850.39
Sep 30, 2022 55,455.09
Jun 30, 2022 62,956.34
Mar 31, 2022 70,707.28
Dec 31, 2021 77,790.02
Sep 30, 2021 3.63 Mn
Jun 30, 2021 2.36 Mn
Mar 31, 2021 1.17 Mn
Dec 31, 2020 60,806.78
Sep 30, 2020 2.38 Mn
Jun 30, 2020 1.59 Mn